筛查性乳腺X线摄影检测自体乳腺重建术后隐匿性恶性肿瘤:15年经验
回顾性分析515例女性618个自体肌皮瓣重建乳房,15年间平均行6.7次筛查性乳腺X线摄影。癌症术后重建乳房的癌症检出率为每1000次筛查1.5例,预防性乳房切除术后为0例;筛查对预防性乳房切除术后重建乳房价值有限。
要点
- 癌症术后自体肌皮瓣重建乳房的筛查性乳腺X线摄影癌症检出率为每1000次筛查1.5例。
- 预防性乳房切除术后重建乳房中未检出局部区域复发,筛查价值有限。
- 筛查性乳腺X线摄影对自体肌皮瓣重建乳房复发的敏感度为42%。
核心结论
- 癌症术后自体肌皮瓣重建乳房的筛查性乳腺X线摄影癌症检出率为每1000次筛查1.5例,与年龄匹配女性单侧天然乳房相当;预防性乳房切除术后筛查性乳腺X线摄影几乎无价值。
研究设计与样本
- 回顾性研究,纳入2000年1月1日至2015年7月15日期间515例女性618个自体肌皮瓣重建乳房,均行乳腺X线摄影且至少1年临床随访。
关键影像表现/征象
- 局部区域复发率为3.9%(20/515例女性;95%CI:2.2%,5.6%),均为浸润性,预防性乳房切除术后重建乳房中未检出。
- 20例局部区域复发中13例(65%)诊断前每年筛查,其中7例(54%)为临床隐匿性复发,乳腺X线摄影检出5例。
- 6例临床明显复发中5例(83%)为间期癌。
- 重建至首次复发的中位时间为4.4年(范围0.8-16.2年)。
诊断标准与关键数值
- 癌症术后重建乳房筛查性乳腺X线摄影癌症检出率为每1000次筛查1.5例(5/3358;95%CI:0.18,2.8),预防性乳房切除术后为每1000次检查0例(0/805;95%CI:0,5)。
- 敏感度42%(5/12),特异度99.4%(4125/4151),阳性预测值16%(5/31),假阳性活检率0.6%(26/4151)。
临床应用与阅片要点
- 癌症术后自体肌皮瓣重建乳房的筛查性乳腺X线摄影癌症检出率与年龄匹配女性单侧天然乳房相当。
- 预防性乳房切除术后自体肌皮瓣重建乳房的筛查性乳腺X线摄影几乎无价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To examine how often screening mammography depicts clinically occult malignancy in breast reconstruction with autologous myocutaneous flaps (AMFs). Materials and Methods Between January 1, 2000, and July 15, 2015, the authors retrospectively identified 515 women who had undergone mammography of 618 AMFs and who had at least 1 year of clinical follow-up. Of the 618 AMFs, 485 (78.5%) were performed after mastectomy for cancer and 133 (21.5%) were performed after prophylactic mastectomy. Medical records were used to determine the frequency, histopathologic characteristics, presentation, time to recurrence, and detection modality of malignancy. Cancer detection rate (CDR), sensitivity, specificity, positive predictive value, and false-positive biopsy rate were calculated. Results An average of 6.7 screening mammograms (range, 1-16) were obtained over 15.5 years. The frequency of local-regional recurrence (LRR) was 3.9% (20 of 515 women; 95% confidence interval [CI]: 2.2%, 5.6%); all LRRs were invasive, and none were detected in the breast mound after prophylactic mastectomy. Of the 20 women with LRR, 13 (65%) were screened annually before the diagnosis. Seven of those 13 women (54%) had clinically occult LRR, and mammography depicted five. Five of the six clinically evident recurrences (83%) were interval cancers. The median time between reconstruction and first recurrence was 4.4 years (range, 0.8-16.2 years). The CDR per AMF was 1.5 per 1000 screening mammograms (five of 3358; 95% CI: 0.18, 2.8) after mastectomy for cancer and 0 of 1000 examinations (0 of 805 mammograms; 95% CI: 0, 5) after prophylactic mastectomy. Sensitivity, specificity, positive predictive value, and false-positive biopsy rate were 42% (five of 12), 99.4% (4125 of 4151), 16% (five of 31), and 0.6% (26 of 4151), respectively. Conclusion The CDR of screening mammography (1.5 per 1000 screening mammograms) of the AMF after mastectomy for cancer is comparable to that for one native breast of an age-matched woman. Screening mammography adds little value after prophylactic mastectomy. © RSNA, 2018.
引用
- Noroozian M, Carlson LW, Savage JL, et al. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience. Radiology. 2018. PMID: 30129903. doi:10.1148/radiol.2018172783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。